Roshni Kulkarni: The Hidden Cost of Underdiagnosed Bleeding Disorders
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
”So glad that the financial impact of delayed diagnosis, under treatment is being recognized.
Thanks Sanjay Ahuja.”
Sanjay Ahuja, Chief Medical Officer at Indiana Hemophilia and Thrombosis Center, shared a post on LinkedIn։
”Women with bleeding disorders remain significantly underdiagnosed and undertreated.
Delays in diagnosis can extend for years, often resulting in repeated emergency visits, chronic anemia, lost productivity and avoidable procedures.
This is not simply a clinical issue. It is a systems and cost issue
Closing this gap for women is not only the right thing to do for patients – it is a high-value, cost-effective investment for any State.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement